Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
5.12
-0.13 (-2.48%)
At close: Jan 21, 2025, 4:00 PM
5.22
+0.10 (1.95%)
After-hours: Jan 21, 2025, 5:20 PM EST
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ENTA stock have an average target of 17.25, with a low estimate of 10 and a high estimate of 21. The average target predicts an increase of 236.91% from the current stock price of 5.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ENTA stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 3 | 2 | 1 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $18 | Strong Buy | Maintains | $27 → $18 | +251.56% | Dec 24, 2024 |
| Baird | Baird | Buy Maintains $26 → $20 | Buy | Maintains | $26 → $20 | +290.62% | Nov 26, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $22 → $21 | Buy | Reiterates | $22 → $21 | +310.16% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +427.34% | Oct 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $22 | Buy | Reiterates | $22 | +329.69% | Oct 9, 2024 |
Financial Forecast
Revenue This Year
73.12M
from 67.64M
Increased by 8.11%
Revenue Next Year
71.62M
from 73.12M
Decreased by -2.05%
EPS This Year
-4.74
from -5.48
EPS Next Year
-4.59
from -4.74
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 115.3M | 114.6M | 240.0M | ||
| Avg | 73.1M | 71.6M | 105.9M | ||
| Low | 55.9M | 31.4M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.5% | 56.8% | 235.1% | ||
| Avg | 8.1% | -2.1% | 47.8% | ||
| Low | -17.4% | -57.1% | -58.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.02 | -3.10 | -1.79 | ||
| Avg | -4.74 | -4.59 | -2.70 | ||
| Low | -5.55 | -6.29 | -3.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.